Director, Nano Institute of Utah; Director, Center for NanoBioSensors, USTAR Professor, Departments of Analytical Chemistry, Chemical Engineering, Bioengineering, and Pathology
office: 801-587-1505 fax: 801-581-6321
Mailing Address: 36 S Wasatch Dr, SMBB 5511, Salt Lake City, UT 84112
The Porter Group’s research aims at innovations central to the discovery and rapid screening of promising therapeutic compounds, nanomaterials, biomaterials, and biocatalysts. By creating high-throughput methods and miniaturizing analytical instrumentation, they are examining issues related, for example, to: (1) micro- and nano- electronic and magnetic devices, (2) biosignatures for health and security, (3) chip-scale diagnostic platforms, and (4) chemical interaction databases. These areas implicitly embody the ability to gain control over the chemistry and physics of liquid-solid interfaces. In research an array of innovations are used in FTIR, STM, AFM, Raman spectroscopy, electrochemistry, fluorescence microscopy, acoustic wave techniques, and spectroelectrochemistry as ultra-sensitive tools for probing these relationships. Design, synthesis, and modification of nanomaterials; plasmonics and spintronics in biotechnology; and advanced separation techniques are focuses of Dr. Porter’s investigations. His research interests span the role of interfaces in analytical chemistry, including electrochemically modulated liquid chromatography, electrocatalysis, organic monolayer films, chemically modified surfaces, scanning probe microscopies, infrared and Raman spectroscopies, and acoustic wave sensors. Ongoing interests also include miniaturized pumps for chip-scale fluidics and high throughput systems for the rapid, low-level pathogen enumeration.